semaglutide eye damage Condition a 'Very Rare' Side Effect of Semaglutide, EMA Says Weight loss drugs linked to

Seek emergency medical attention (call 999) for persistent vomiting, severe hypoglycaemia, confusion, or loss of consciousness

A dedicated phase 2a substudy in people with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) used MRI to measure liver fat and found that, after 24 weeks, retatrutide reduced relative liver-fat content by about 81% at the 8 mg dose and about 82% at 12 mg, versus essentially no change on placebo

Expanding marketing efforts and endorsements from healthcare professionals are increasing patient awareness and uptake

Together, these pathways generate a proliferative bias, shifting the -cell compartment toward expansion

Passclaim--body weight regulation, insulin sensitivity and diabetes risk